Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNQ3 | O43525 | 1/20 | 0.41 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.41 |
| ▸ | CHIT1 | Q13231 | 1/20 | 0.39 |
| ▸ | CHIA | Q9BZP6 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | MAOB | P27338 | 1/20 | 0.36 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.35 |
| ▸ | SLC2A4 | P14672 | 1/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL416586 | 1.00 | KCNQ3 (0.41) | KCNQ3KCNQ2CHIT1CHIAMAPK1 | |
| SCHEMBL29525674 | 1.00 | KCNQ3 (0.41) | KCNQ3KCNQ2CHIT1CHIAMAPK1 | |
| SCHEMBL15247100 | 0.91 | KCNQ3 (0.38) | KCNQ3KCNQ2CHIT1CHIAMAPK1 | |
| SCHEMBL19816909 | 0.86 | MAPK1 (0.53) | MAPK1KDM4EL3MBTL1MAOBHDAC3 | |
| SCHEMBL6726742 | 0.86 | KMT2A (0.50) | KCNQ3KCNQ2MAPK1KDM4EL3MBTL1 | |
| SCHEMBL29815064 | 0.85 | NAPRT (0.47) | KCNQ3KCNQ2L3MBTL1NPC1RAB9A | |
| SCHEMBL19360803 | 0.85 | MAPK1 (0.37) | MAPK1KDM4EL3MBTL1MAOBHDAC3 | |
| SCHEMBL10001386 | 0.85 | NAPRT (0.47) | KCNQ3KCNQ2L3MBTL1NPC1RAB9A | |
| SCHEMBL17544977 | 0.84 | ALOX5AP (0.41) | MAPK1KDM4EL3MBTL1MAOBHDAC3 | |
| SCHEMBL30563841 | 0.83 | KCNQ3 (0.43) | KCNQ3KCNQ2CHIT1CHIAMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250388523-A1 | 18F-LABELED PEPTIDE LIGANDS USEFUL IN PET AND CERENKOV LUMINESCENE IMAGING | CORNELL UNIVERSITY (US) | 2025-12-25 | — | — | US | disclosed |
| US-12297157-B2 | 18F-labeled peptide ligands useful in PET and Cerenkov luminescene imaging | CORNELL UNIVERSITY (US) | 2025-05-13 | — | — | US | disclosed |
| US-12016936-B2 | Neovascular-targeting contrast medium composition and method for preparing same | KOREA BASIC SCIENCE INSTITUTE (KR) | 2024-06-25 | — | — | US | disclosed |
| EP-4249005-A2 | 18F-LABELED TRIAZOLE CONTAINING PSMA INHIBITORS | Cornell University (US) | 2023-09-27 | — | — | EP | disclosed |
| US-20230271923-A1 | IMAGING AND TARGETING PROGRAMMED DEATH LIGAND-1 (PD-LI) EXPRESSION | THE JOHNS HOPKINS UNIVERSTY | 2023-08-31 | — | — | US | disclosed |
| EP-3493856-B1 | 18F-LABELED TRIAZOLE CONTAINING PSMA INHIBITORS | UNIV CORNELL (US) | 2023-08-09 | — | — | EP | disclosed |
| US-20220194904-A1 | 18F-LABELED TRIAZOLE CONTAINING PSMA INHIBITORS | CORNELL UNIVERSITY (US) | 2022-06-23 | — | — | US | disclosed |
| WO-2018048856-A1 | METHOD FOR EFFICIENT RADIOLABELING OF BIOMOLECULES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2018-03-15 | — | — | WO | disclosed |
| US-20130251632-A1 | APOPTOSIS PET IMAGING AGENTS | GE HEALTHCARE LIMITED (GB) | 2013-09-26 | — | — | US | disclosed |
| US-8530620-B2 | Radiolabelling reagents and methods | GE HEALTHCARE LIMITED (GB) | 2013-09-10 | — | — | US | disclosed |
| US-20120121509-A1 | VITAL FLUOROCHROME CONJUGATES AND METHODS OF USE | THE GENERAL HOSPITAL CORPORATION (US) | 2012-05-17 | — | — | US | disclosed |
| US-20120022227-A1 | RADIOLABELLING REAGENTS AND METHODS | GE HEALTHCARE LIMITED (GB) | 2012-01-26 | — | — | US | disclosed |
| US-20110142760-A1 | PSMA-BINDING AGENTS AND USES THEREOF | THE JOHNS HOPKINS UNIVERSITY (US) | 2011-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110142760-A1 | PSMA-BINDING AGENTS AND USES THEREOF | KLK3, FOLH1, DNPEP | KCNQ3 3231/4885KCNQ2 2397/4885CHIT1 2912/4885 |
| US-12016936-B2 | Neovascular-targeting contrast medium composition and method for preparing same | ITGAV, VCAM1, ITGB3 | KCNQ3 1683/4885KCNQ2 2635/4885CHIT1 2387/4885 |
| US-20250388523-A1 | 18F-LABELED PEPTIDE LIGANDS USEFUL IN PET AND CERENKOV LUMINESCENE IMAGING | SCTR, SSTR3, SSTR1 | KCNQ3 787/4885KCNQ2 1467/4885CHIT1 1052/4885 |
| US-20120121509-A1 | VITAL FLUOROCHROME CONJUGATES AND METHODS OF USE | CASP3, CASP7, CD47 | KCNQ3 2999/4885KCNQ2 3413/4885CHIT1 2108/4885 |
| US-20230271923-A1 | IMAGING AND TARGETING PROGRAMMED DEATH LIGAND-1 (PD-LI) EXPRESSION | CD274, PDCD1LG2, PDCD1 | KCNQ3 4749/4885KCNQ2 4774/4885CHIT1 701/4885 |
| US-12297157-B2 | 18F-labeled peptide ligands useful in PET and Cerenkov luminescene imaging | VIP, CALCA, GLP1R | KCNQ3 2483/4885KCNQ2 2503/4885CHIT1 477/4885 |
| US-20130251632-A1 | APOPTOSIS PET IMAGING AGENTS | BAX, CASP3, PHOSPHO1 | KCNQ3 2219/4885KCNQ2 2616/4885CHIT1 4080/4885 |
| US-20120022227-A1 | RADIOLABELLING REAGENTS AND METHODS | ANPEP, DNPEP, QRFPR | KCNQ3 2450/4885KCNQ2 2854/4885CHIT1 1989/4885 |
| US-20220194904-A1 | 18F-LABELED TRIAZOLE CONTAINING PSMA INHIBITORS | PSMA3, FOLH1, PSMA1 | KCNQ3 2022/4885KCNQ2 3151/4885CHIT1 2147/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.